Concepedia

Publication | Open Access

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

31

Citations

16

References

2023

Year

Abstract

US Food and Drug Administration Office of Orphan Products Development and Orphazyme.

References

YearCitations

Page 1